Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1"
topic_facet:"Lymphoma"
publishDate:"[2020 TO 2029]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=topic_facet%3A%22Lymphoma%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=topic_facet%3A%22Lymphoma%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=topic_facet%3A%22Lymphoma%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (910)
1
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin Lymphoma : Phase 1b/2, Open-Label Trial to Evaluate Safety and Preliminary Efficacy of Epcoritamab As Monotherapy or Combined With Standard-of-Care Therapies in Chinese Subjects With B-Cell Non-Hodgkin Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab : A Single Arm, Open-Label, Phase 1b Trial of Epcoritamab in Pediatric Patients With Relapsed/Refractory Aggressive Mature B-cell Neoplasms
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Safety Study of SGN-35T in Adults With Advanced Cancers : An Open-label Phase 1 Study to Evaluate the Safety of SGN-35T in Adults With Advanced Malignancies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Study of NX-1607 in Adults With Advanced Malignancies : A Phase 1a, Dose Escalation, Safety and Tolerability Study of NX-1607, a Casitas B-lineage Lymphoma Proto-oncogene (CBL-B) Inhibitor, in Adults With Advanced Malignancies, With Phase 1b Expansion in Select Tumor Types
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas : A Phase 1, Multi-Center, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of BMS-986458, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed/Refractory Non-Hodgkin Lymphomas (R/R NHL)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation : Administration of Anti-CD19-Chimeric-Antigen-Receptor-Transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-Cell Malignancies After Allogeneic Stem Cell Transplantation
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Venetoclax and Selinexor in Treating Patients With Relapsed or Refractory High Risk Hematologic Malignancies : An Investigator-Sponsored Phase Ib Trial of Venetoclax and SINE: Selective Inhibition of Nuclear Export in Patients With High Risk Hematologic Malignancies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants : A Phase 1, Open-label, Multicenter Study of SYNB1891 Administered by Intratumoral Injection to Patients With Advanced/Metastatic Solid Tumors and Lymphoma Alone and in Combination With Atezolizumab
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Study of Feasibility and Safety of UCD19 Chimeric Antigen Receptor (CAR) T Cells in Adult Subjects With Relapsed/Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (B-NHL) : Phase I Study of Feasibility and Safety of UCD19 Chimeric Antigen Receptor (CAR) T Cells in Adult Subjects With Relapsed/Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (B-NHL)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma : An Open-label, Multi-center, Non-randomized Phase I Dose Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ONO-4685 Given as Monotherapy in Patients With Relapsed or Refractory T Cell Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[91]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 1
Filter aufheben
Thema: Lymphoma
Filter aufheben
Erscheinungsjahr: 2020-2029
Medienart
910
Aufsätze
910
E-Artikel
910
E-Ressourcen
Zeitschriftentitel
910
ClinicalTrials.gov
Thema
910
610
Lymphoma
Phase: Phase 1
910
Study Type: Interventional
367
Lymphoma, Non-Hodgkin
340
Lymphoma, B-Cell
303
Recruitment Status: Recruiting
238
Recruitment Status: Completed
231
Lymphoma, Large B-Cell, Diffuse
193
Recruitment Status: Active, not recruiting
186
Leukemia
161
Leukemia, Lymphocytic, Chronic, B-Cell
145
Leukemia, Lymphoid
123
Lymphoma, Mantle-Cell
106
Lymphoma, T-Cell
101
Lymphoma, Follicular
99
Precursor Cell Lymphoblastic Leukemia-Lymphoma
95
Neoplasms
95
Recurrence
87
Recruitment Status: Terminated
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2020-
358
2024
281
2023
101
2022
89
2021
81
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
910
Englisch
Haven't found what you're looking for?
Wird geladen...